The Human Peroxisome Proliferator-activated Receptor δ Gene is a Primary Target of 1α,25-Dihydroxyvitamin D3 and its Nuclear Receptor
- 1 June 2005
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 349 (2), 248-260
- https://doi.org/10.1016/j.jmb.2005.03.060
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Principles for modulation of the nuclear receptor superfamilyNature Reviews Drug Discovery, 2004
- Be Fit or Be Sick: Peroxisome Proliferator-Activated Receptors Are Down the RoadMolecular Endocrinology, 2004
- Peroxisome Proliferator-activated Receptor β (δ)-dependent Regulation of Ubiquitin C Expression Contributes to Attenuation of Skin CarcinogenesisJournal of Biological Chemistry, 2004
- Peroxisome proliferator–activated receptor-δ attenuates colon carcinogenesisNature Medicine, 2004
- Vitamin D: More Than a “Bone-a-Fide” HormoneMolecular Endocrinology, 2003
- The Mechanisms of Action of PPARsAnnual Review of Medicine, 2002
- Nuclear Receptors and Lipid Physiology: Opening the X-FilesScience, 2001
- Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesisFrontiers in Bioscience-Landmark, 2001
- Prostacyclin-mediated activation of peroxisome proliferator-activated receptor δ in colorectal cancerProceedings of the National Academy of Sciences, 2000
- PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory DrugsCell, 1999